4//SEC Filing
Feitel David 4
Accession 0001209191-11-014039
CIK 0000892025other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 7:28 PM ET
Size
19.7 KB
Accession
0001209191-11-014039
Insider Transaction Report
Form 4
Feitel David
Sr VP, Gen Counsel & Secretary
Transactions
- Exercise/Conversion
Restricted Stock Units
2011-02-25−17,027→ 0 total→ Common Stock (17,027 underlying) - Disposition to Issuer
Common Stock
2011-02-25$31.50/sh−31,881$1,004,252→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2011-02-25$3.64/sh−10,000$36,400→ 0 totalExercise: $27.83Exp: 2016-01-05→ Common Stock (10,000 underlying) - Exercise/Conversion
Restricted Stock Units
2011-02-25−3,039→ 0 total→ Common Stock (3,039 underlying) - Award
Common Stock
2011-02-25+31,881→ 31,881 total - Exercise/Conversion
Restricted Stock Units
2011-02-25−2,836→ 0 total→ Common Stock (2,836 underlying) - Exercise/Conversion
Restricted Stock Units
2011-02-25−8,709→ 0 total→ Common Stock (8,709 underlying)
Footnotes (8)
- [F1]Represents shares of Martek's common stock acquired on the vesting of restricted stock units originally granted in January 2007, 2008, 2009 and 2010. Pursuant to Martek's Amended and Restated 2004 Stock Incentive Plan and the Agreement and Plan of Merger, dated December 20, 2010, between Martek, Koninklijke DSM N.V. and Greenback Acquisition Corporation ("Purchaser"), immediately prior to the consummation of the merger of Purchaser (the "Merger") with and into Martek, the restricted stock units vested in full and were settled for shares of common stock with the right to receive the per share Merger consideration of $31.50. The Merger was consummated on February 25, 2011.
- [F2]Disposed of pursuant to the Merger.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Martek common stock.
- [F4]These restricted stock units, which were part of a grant in January 2007 that vested in five annual installments beginning in March 2008, had their vesting accelerated pursuant to the Merger Agreement and were settled for shares of common stock of Martek.
- [F5]These restricted stock units, which were part of a grant in January 2008 that vested in five annual installments beginning in March 2009, had their vesting accelerated pursuant to the Merger Agreement and were settled for shares of common stock of Martek.
- [F6]These restricted stock units, which were part of a grant in January 2009 that vested in five annual installments beginning in March 2010, had their vesting accelerated pursuant to the Merger Agreement and were settled for shares of common stock of Martek.
- [F7]These restricted stock units, which were part of a grant in January 2010 that were to vest in five annual installments beginning in March 2011, had their vesting accelerated pursuant to the Merger Agreement and were settled for shares of common stock of Martek.
- [F8]This option was cancelled in the merger in exchange for a cash payment equal to the difference between the exercise price of the option and the $31.50 consideration payable in the merger for each share of Martek common stock.
Documents
Issuer
MARTEK BIOSCIENCES CORP
CIK 0000892025
Entity typeother
Related Parties
1- filerCIK 0001385249
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 7:28 PM ET
- Size
- 19.7 KB